• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用ITK-SNAP对放射学变化进行定量分割分析:颌骨药物相关性骨坏死严重程度和复发的风险评估

Quantitative Segmentation Analysis of the Radiological Changes by Using ITK-SNAP: Risk Assessment of the Severity and Recurrence of Medication-related Osteonecrosis of the Jaw.

作者信息

Zhou Yu-Qiong, Son Gee-Hun, Shi Yue-Qi, Yu Ye-Jia, Li Meng-Yu, Zhang Qin, Zou Duo-Hong, Zhang Zhi-Yuan, Yang Chi, Wang Shao-Yi

机构信息

Shanghai Ninth People's Hospital, Collage of Stomatology, Shanghai Jiao Tong University School of Medicine (200011); National Clinical Research Center of Oral Disease; Shanghai Key Laboratory of Stomatology & Shanghai Research Institute of Stomatology, Department of Oral Surgery.

出版信息

Int J Med Sci. 2021 Mar 24;18(10):2209-2216. doi: 10.7150/ijms.56408. eCollection 2021.

DOI:10.7150/ijms.56408
PMID:33859529
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8040413/
Abstract

Medication-related osteonecrosis of the jaw (MRONJ) severely impairs patients' quality of life and is remarkably refractory to treatment. There are lots of studies about identification of the radiographic features of MRONJ, yet reports about quantitative radiographic analysis for the risk assessment of the severity and recurrence of MRONJ are rarely heard. The aim of this study was to investigate the volumes of osteolytic lesions and radiodensity values of osteosclerotic lesions in MRONJ patients by using ITK-SNAP for severity prediction and prognosis evaluation. Of 78 MRONJ patients (78 lesions) involved in this retrospective study, 53 were presented as osteolytic lesions and 25 were presented as osteosclerotic changes alone. Comprehensive CBCT images, demographics and clinical data of patients were investigated. The volumetric analysis and radiodensity measurement were performed by ITK-SNAP. SPSS 25.0 were used for statistical analysis. The osteolytic lesion volumes in MRONJ patients receiving intravenous bisphosphonates (P=0.004) and patients without osteoporosis (P=0.027) were significantly large. No significant correlation between the volumes and bisphosphonates duration was found (P=0.094). The radiodensity values of osteosclerotic lesions was significantly correlated with bisphosphonates duration (P=0.040). The surrounding area of post-surgical lesions in MRONJ patients with recurrence showed significantly great radiodensity values (P=0.025). No significant correlation between the radiodensity values and the transformation from osteosclerotic lesions to osteolytic lesions was observed (P=0.507). MRONJ patients receiving intravenous bisphosphonates develop into large volumes of osteolytic lesions more easily. Long-term bisphosphonates duration is possibly related with higher bone density of osteosclerotic lesions, while higher density is not associated with the transformation from osteosclerotic lesions to osteolytic lesions. A rise of bone mineral density nearby post-surgical lesions is probably a predictor for MRONJ recurrence.

摘要

药物相关性颌骨坏死(MRONJ)严重损害患者的生活质量,且治疗极具挑战性。关于MRONJ影像学特征识别的研究众多,但关于MRONJ严重程度和复发风险评估的定量影像学分析报道却很少。本研究旨在通过使用ITK-SNAP软件研究MRONJ患者溶骨性病变的体积和骨硬化性病变的骨密度值,以进行严重程度预测和预后评估。在这项回顾性研究纳入的78例MRONJ患者(78处病变)中,53例表现为溶骨性病变,25例仅表现为骨硬化性改变。研究了患者的综合CBCT图像、人口统计学和临床数据。通过ITK-SNAP进行体积分析和骨密度测量。使用SPSS 25.0进行统计分析。接受静脉注射双膦酸盐治疗的MRONJ患者(P = 0.004)和无骨质疏松症的患者(P = 0.027)的溶骨性病变体积明显更大。未发现病变体积与双膦酸盐使用时长之间存在显著相关性(P = 0.094)。骨硬化性病变的骨密度值与双膦酸盐使用时长显著相关(P = 0.040)。复发的MRONJ患者术后病变周围区域的骨密度值显著更高(P = 0.025)。未观察到骨密度值与骨硬化性病变向溶骨性病变转变之间存在显著相关性(P = 0.507)。接受静脉注射双膦酸盐治疗的MRONJ患者更容易发展为大面积溶骨性病变。双膦酸盐长期使用可能与骨硬化性病变的骨密度较高有关,而较高的骨密度与骨硬化性病变向溶骨性病变的转变无关。术后病变附近骨密度的升高可能是MRONJ复发的一个预测指标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfca/8040413/f9cb62a18fe9/ijmsv18p2209g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfca/8040413/4ce03ae414b5/ijmsv18p2209g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfca/8040413/212012cbca1d/ijmsv18p2209g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfca/8040413/d7a25df872e2/ijmsv18p2209g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfca/8040413/e8bac38ace21/ijmsv18p2209g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfca/8040413/982b96ace13f/ijmsv18p2209g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfca/8040413/8f9a7d9a6d29/ijmsv18p2209g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfca/8040413/f9cb62a18fe9/ijmsv18p2209g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfca/8040413/4ce03ae414b5/ijmsv18p2209g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfca/8040413/212012cbca1d/ijmsv18p2209g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfca/8040413/d7a25df872e2/ijmsv18p2209g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfca/8040413/e8bac38ace21/ijmsv18p2209g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfca/8040413/982b96ace13f/ijmsv18p2209g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfca/8040413/8f9a7d9a6d29/ijmsv18p2209g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfca/8040413/f9cb62a18fe9/ijmsv18p2209g007.jpg

相似文献

1
Quantitative Segmentation Analysis of the Radiological Changes by Using ITK-SNAP: Risk Assessment of the Severity and Recurrence of Medication-related Osteonecrosis of the Jaw.使用ITK-SNAP对放射学变化进行定量分割分析:颌骨药物相关性骨坏死严重程度和复发的风险评估
Int J Med Sci. 2021 Mar 24;18(10):2209-2216. doi: 10.7150/ijms.56408. eCollection 2021.
2
Bisphosphonate application and volumetric effects on MRONJ lesions.双膦酸盐的应用及对 MRONJ 病变的容积效应。
J Craniomaxillofac Surg. 2021 Jun;49(6):501-507. doi: 10.1016/j.jcms.2021.01.014. Epub 2021 Feb 5.
3
Volumetric analysis of MRONJ lesions by semiautomatic segmentation of CBCT images.通过CBCT图像的半自动分割对MRONJ病变进行容积分析。
Oral Maxillofac Surg. 2019 Dec;23(4):465-472. doi: 10.1007/s10006-019-00805-x. Epub 2019 Oct 31.
4
Medication-related osteonecrosis of the jaw: risk factors in patients under biphosphonate versus patients under antiresorptive-antiangiogenic drugs.药物相关性颌骨坏死:双膦酸盐治疗患者与抗吸收-抗血管生成药物治疗患者的风险因素
Minerva Stomatol. 2017 Aug;66(4):135-140. doi: 10.23736/S0026-4970.17.04056-0. Epub 2017 May 10.
5
Surgical therapy for medication-related osteonecrosis of the jaw in osteoporotic patients treated with antiresorptive agents.抗吸收剂治疗骨质疏松症患者药物相关性颌骨坏死的手术治疗。
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2020 Mar;164(1):100-107. doi: 10.5507/bp.2018.081. Epub 2019 Jan 10.
6
Interventions for managing medication-related osteonecrosis of the jaw.颌骨药物相关性骨坏死的管理干预措施。
Cochrane Database Syst Rev. 2017 Oct 6;10(10):CD012432. doi: 10.1002/14651858.CD012432.pub2.
7
A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients receiving oral bisphosphonate therapy: can primary wound closure and a drug holiday really prevent MRONJ?一项多中心回顾性研究,探讨了接受口服双膦酸盐治疗的拔牙后药物相关性颌骨坏死的相关风险因素:原发伤口闭合和药物暂停真的能预防 MRONJ 吗?
Osteoporos Int. 2017 Aug;28(8):2465-2473. doi: 10.1007/s00198-017-4063-7. Epub 2017 Apr 27.
8
Key insights into antiresorptive drug use and osteonecrosis in osteoporotic patients undergoing tooth extractions: A clinical and CBCT assessment.抗吸收药物在骨质疏松症患者拔牙中应用与骨坏死的临床和 CBCT 评估:关键见解。
Osteoporos Int. 2024 Aug;35(8):1431-1440. doi: 10.1007/s00198-024-07108-2. Epub 2024 May 20.
9
CT imaging features of antiresorptive agent-related osteonecrosis of the jaw/medication-related osteonecrosis of the jaw.抗吸收剂相关性颌骨坏死/药物相关性颌骨坏死的 CT 影像学特征。
Dentomaxillofac Radiol. 2018 May;47(4):20170323. doi: 10.1259/dmfr.20170323. Epub 2018 Feb 13.
10
Combined Administration of Bisphosphonates, Chemotherapeutic Agents, and/or Targeted Drugs Increases the Risk for Stage 3 Medication-Related Osteonecrosis of the Jaw: A 4-Year Retrospective Study.联合应用双膦酸盐、化疗药物和/或靶向药物会增加 3 级药物相关性颌骨坏死的风险:一项为期 4 年的回顾性研究。
Biomed Res Int. 2020 Oct 15;2020:5847429. doi: 10.1155/2020/5847429. eCollection 2020.

引用本文的文献

1
Medication-related osteonecrosis of the jaw: a retrospective single center study of recurrence-related factors after surgical treatment.药物相关性颌骨坏死:手术治疗后复发相关因素的回顾性单中心研究。
Clin Oral Investig. 2024 Sep 25;28(10):549. doi: 10.1007/s00784-024-05911-z.
2
The Role of Cone Beam Computed Tomography (CBCT) in the Diagnosis and Clinical Management of Medication-Related Osteonecrosis of the Jaw (MRONJ).锥形束计算机断层扫描(CBCT)在颌骨药物相关性骨坏死(MRONJ)诊断及临床管理中的作用
Diagnostics (Basel). 2024 Aug 6;14(16):1700. doi: 10.3390/diagnostics14161700.
3
A support vector machine-based algorithm to identify bisphosphonate-related osteonecrosis throughout the mandibular bone by using cone beam computerized tomography images.

本文引用的文献

1
A comparison of the cone beam computed tomography findings in medication-related osteonecrosis of the jaws related to denosumab versus bisphosphonates: an observational pilot study.比较 denosumab 与双膦酸盐相关的药物相关性颌骨骨坏死的锥形束 CT 表现:一项观察性初步研究。
Oral Surg Oral Med Oral Pathol Oral Radiol. 2020 Apr;129(4):411-417. doi: 10.1016/j.oooo.2019.09.010. Epub 2019 Sep 26.
2
Computed tomography imaging features of osteomyelitis of the jaw: comparison between antiresorptive medication-related conditions and medication-unrelated conditions.颌骨骨髓炎的计算机断层成像特征:抗吸收药物相关情况与非药物相关情况的比较。
Oral Surg Oral Med Oral Pathol Oral Radiol. 2020 Jun;129(6):629-634. doi: 10.1016/j.oooo.2019.11.006. Epub 2019 Nov 14.
3
基于支持向量机的算法,利用锥形束计算机断层扫描图像识别下颌骨中的双膦酸盐相关性骨坏死。
Dentomaxillofac Radiol. 2023 Apr;52(4):20220390. doi: 10.1259/dmfr.20220390. Epub 2023 Apr 13.
4
Structural insights into the binding of zoledronic acid with RANKL computational simulations.唑来膦酸与RANKL结合的结构见解:计算模拟
Front Mol Biosci. 2022 Sep 19;9:992473. doi: 10.3389/fmolb.2022.992473. eCollection 2022.
5
Deep Learning With Radiomics for Disease Diagnosis and Treatment: Challenges and Potential.基于影像组学的深度学习在疾病诊断与治疗中的挑战与潜力
Front Oncol. 2022 Feb 17;12:773840. doi: 10.3389/fonc.2022.773840. eCollection 2022.
6
Characterization of Mesenchymal Stem Cells Derived from Bisphosphonate-Related Osteonecrosis of the Jaw Patients' Gingiva.来源于双膦酸盐相关性颌骨骨坏死患者牙龈的间充质干细胞的特征。
Stem Cell Rev Rep. 2022 Jan;18(1):378-394. doi: 10.1007/s12015-021-10241-8. Epub 2021 Sep 22.
Clinical and panoramic radiographic features of osteomyelitis of the jaw: A comparison between antiresorptive medication-related and medication-unrelated conditions.颌骨骨髓炎的临床和全景放射学特征:抗吸收药物相关与非药物相关情况的比较。
Imaging Sci Dent. 2019 Dec;49(4):287-294. doi: 10.5624/isd.2019.49.4.287. Epub 2019 Dec 24.
4
Volumetric analysis of MRONJ lesions by semiautomatic segmentation of CBCT images.通过CBCT图像的半自动分割对MRONJ病变进行容积分析。
Oral Maxillofac Surg. 2019 Dec;23(4):465-472. doi: 10.1007/s10006-019-00805-x. Epub 2019 Oct 31.
5
Medication-Related Osteonecrosis of the Jaw: MASCC/ISOO/ASCO Clinical Practice Guideline.药物相关性颌骨坏死:MASCC/ISOO/ASCO 临床实践指南。
J Clin Oncol. 2019 Sep 1;37(25):2270-2290. doi: 10.1200/JCO.19.01186. Epub 2019 Jul 22.
6
Effects of zoledronic acid and dexamethasone on early phases of socket healing after tooth extraction in rats: A preliminary macroscopic and microscopic quantitative study.唑来膦酸和地塞米松对大鼠拔牙后牙槽窝愈合早期的影响:一项初步的宏观和微观定量研究。
Med Oral Patol Oral Cir Bucal. 2019 May 1;24(3):e339-e345. doi: 10.4317/medoral.22883.
7
Medication related osteonecrosis of the jaw in osteoporotic oncologic patients-quantifying radiographic appearance and relationship to clinical findings.骨质疏松性肿瘤患者的药物相关性颌骨坏死——影像学表现量化及其与临床发现的关系
Dentomaxillofac Radiol. 2019 Jan;48(1):20180128. doi: 10.1259/dmfr.20180128. Epub 2018 Jun 28.
8
Medication related osteonecrosis of the jaws associated with targeted therapy as monotherapy and in combination with antiresorptives. A report of 7 cases from the Copenhagen Cohort.与靶向治疗单药及联合抗骨吸收药物相关的颌骨药物性骨坏死。来自哥本哈根队列的7例报告。
Oral Surg Oral Med Oral Pathol Oral Radiol. 2018 Feb;125(2):157-163. doi: 10.1016/j.oooo.2017.10.010. Epub 2017 Nov 6.
9
Osseous changes in patients with medication-related osteonecrosis of the jaws.药物相关性颌骨坏死患者的骨质改变
Dentomaxillofac Radiol. 2018 Jan;47(1):20170172. doi: 10.1259/dmfr.20170172. Epub 2017 Nov 1.
10
Bisphosphonates for cancer treatment: Mechanisms of action and lessons from clinical trials.双膦酸盐类药物在癌症治疗中的应用:作用机制及临床试验的启示。
Pharmacol Ther. 2016 Feb;158:24-40. doi: 10.1016/j.pharmthera.2015.11.008. Epub 2015 Nov 23.